Jones Walker advises life sciences companies, investors, and strategic acquirers on mergers, acquisitions, divestitures, and other transformative transactions across the healthcare and life sciences spectrum. Our attorneys have represented publicly traded and private buyers and sellers in complex domestic and international M&A transactions, including whole-company acquisitions and divestitures, carve-outs, stock and asset purchases, recapitalizations, joint ventures, tender offers, and licensing-driven transactions. We understand the unique regulatory, intellectual property, commercialization, and valuation considerations that shape life sciences M&A transactions and help clients structure and execute deals that advance strategic objectives. Our team combines sophisticated transactional experience with a practical, business-minded approach to managing risk and driving successful outcomes.